title: Can cytokine adsorber treatment affect antibiotic concentrations? A case report.
authors: Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany michael.zoller@med.uni-muenchen.de.
authors: Michael
authors: M
authors: Zoller
authors: Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
authors: Gundula
authors: G
authors: Döbbeler
authors: Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
authors: Barbara
authors: B
authors: Maier
authors: Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
authors: Michael
authors: M
authors: Vogeser
authors: Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
authors: Lorenz
authors: L
authors: Frey
authors: Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany.
authors: Johannes
authors: J
authors: Zander
mesh_terms: D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016638:Critical Illness; D016207:Cytokines / Q000037:antagonists & inhibitors*; D004347:Drug Interactions; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D010949:Plasma / Q000737:chemistry*; D012772:Shock, Septic / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D016207:Cytokines; D007155:Immunologic Factors
keywords: ICUs; antibiotic therapy; bacterial infections; drug monitoring; in vivo; intensive care units; linezolid; meropenem; septic shock; septicaemia; therapeutic drug monitoring